Magnetic resonance in the era of molecular imaging of cancer
Authors:
- John C. GoreJGJohn C. Gore
- H. Charles ManningHMH. Charles Manning
- C. Chad QuarlesCQC. Chad Quarles
- Kevin W. WaddellKWKevin W. Waddell
- Thomas E. YankeelovTYThomas E. Yankeelov
- 1 June 2011
- journal article
- review article
- Published by Elsevier in Magnetic Resonance Imaging
- Vol. 29 (5) , 587-600
Abstract
No abstract availableKeywords
This publication has 96 references indexed in Scilit:
- A Responsive Europium(III) Chelate That Provides a Direct Readout of pH by MRIJournal of the American Chemical Society, 2010
- Production of hyperpolarized [1,4- 13 C 2 ]malate from [1,4- 13 C 2 ]fumarate is a marker of cell necrosis and treatment response in tumorsProceedings of the National Academy of Sciences, 2009
- A theoretical framework to model DSC-MRI data acquired in the presence of contrast agent extravasationPhysics in Medicine & Biology, 2009
- Imaging the tissue distribution of glucose in livers using a PARACEST sensorMagnetic Resonance in Medicine, 2008
- Noninvasive monitoring of radiation-induced treatment response using proton magnetic resonance spectroscopy and diffusion-weighted magnetic resonance imaging in a colorectal tumor modelRadiotherapy and Oncology, 2007
- Improved tumor vascular function following high-dose epidermal growth factor receptor tyrosine kinase inhibitor therapyJournal of Magnetic Resonance Imaging, 2007
- MRI detection of glycogen in vivo by using chemical exchange saturation transfer imaging (glycoCEST)Proceedings of the National Academy of Sciences, 2007
- Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial resultsMagnetic Resonance Imaging, 2007
- Paramagnetic lanthanide complexes as PARACEST agents for medical imagingChemical Society Reviews, 2006
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI: Journal of the National Cancer Institute, 2000